Holdings of Jones Hill Capital LP
25 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 73.8 % of the equity sleeve
Sector breakdown
- Health care 14.6 %
- Unattributed 85.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 95.5 %
- NL 4.1 %
- GB 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 23 | 441.2M $ | 95.54 % |
| 2 | NL | 1 | 19M $ | 4.11 % |
| 3 | GB | 1 | 1.6M $ | 0.34 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | BioMarin Pharmaceutical Inc | 1,268,390 | 71.7M $ | |
| 2 | Vertex Pharmaceuticals Inc | 108,603 | 48.5M $ | |
| 3 | Vaxcyte Inc | 644,831 | 37.5M $ | |
| 4 | Nuvalent Inc | 300,830 | 30.8M $ | |
| 5 | Capricor Therapeutics Inc | 909,207 | 27.6M $ | |
| 6 | Terns Pharmaceuticals Inc | 521,237 | 27.5M $ | |
| 7 | Bicara Therapeutics Inc | 1,260,136 | 25.1M $ | |
| 8 | ANI Pharmaceuticals Inc | 318,591 | 24.5M $ | |
| 9 | Ultragenyx Pharmaceutical Inc | 1,165,557 | 24.4M $ | |
| 10 | Enliven Therapeutics Inc | 593,040 | 23.2M $ | |
| 11 | Amylyx Pharmaceuticals Inc | 1,598,794 | 22.2M $ | |
| 12 | Argenx SE | 25,995 | 19M $ | |
| 13 | Fulcrum Therapeutics Inc | 1,771,926 | 13.6M $ | |
| 14 | Vir Biotechnology Inc | 1,198,213 | 10.7M $ | |
| 15 | Nuvation Bio Inc | 2,383,031 | 10.2M $ | |
| 16 | Oruka Therapeutics Inc | 140,843 | 6.9M $ | |
| 17 | Contineum Therapeutics Inc | 513,053 | 6.7M $ | |
| 18 | VeraDermics Inc | 100,843 | 6.4M $ | |
| 19 | Tonix Pharmaceuticals Holding Corp | 452,116 | 6.2M $ | |
| 20 | Structure Therapeutics Inc | 100,593 | 4.8M $ | |
| 21 | Entrada Therapeutics Inc | 374,010 | 4.7M $ | |
| 22 | Trevi Therapeutics Inc | 370,175 | 4.4M $ | |
| 23 | Relmada Therapeutics Inc | 342,752 | 2.4M $ | |
| 24 | Silence Therapeutics PLC | 301,604 | 1.6M $ | |
| 25 | ArriVent Biopharma Inc | 45,809 | 1.1M $ | |